Stock image Linagliptin
Prague,Czech Republic-June 17 2024:JENTADUETO Box With Linagliptin And Metformin Active Substance By Boehringer Ingelheim,used For Treatment Of Type 2 Diabetes,High Blood Sugar,Insulin Resistance
Image, 2.15MB, 4032 × 3024 jpg
Prague,Czech Republic-August 10 2024: JENTADUETO Box Of Tablets With LINAGLIPTIN And METFORMIN Active Substances, Used For Treatment Of Type 2 Diabetes, Blood Sugar Control.
Image, 2.08MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: JENTADUETO Box Of Medication With LINAGLIPTIN And METFORMIN Active Substances By BOEHRINGER INGELHEIM, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.21MB, 3024 × 4032 jpg
Prague,Czech Republic-June 17 2024:JENTADUETO Box With Linagliptin And Metformin Active Substance By Boehringer Ingelheim,used For Treatment Of Type 2 Diabetes,High Blood Sugar,Insulin Resistance
Image, 2.22MB, 4032 × 3024 jpg
Prague,Czech Republic-August 10 2024: JENTADUETO Box Of Tablets With LINAGLIPTIN And METFORMIN Active Substances, Used For Treatment Of Type 2 Diabetes, Blood Sugar Control.
Image, 2.17MB, 3024 × 4032 jpg
Prague, Czech Republic - July 10 2024: JENTADUETO Box Of Medication With LINAGLIPTIN And METFORMIN Active Substances By BOEHRINGER INGELHEIM, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.23MB, 4032 × 3024 jpg
Prague,Czech Republic-June 17 2024:JENTADUETO Box With Linagliptin And Metformin Active Substance By Boehringer Ingelheim,used For Treatment Of Type 2 Diabetes,High Blood Sugar,Insulin Resistance
Image, 2.2MB, 4032 × 3024 jpg
Linagliptin Or Tradjenta Is A Medication Used To Treat Diabetes Mellitus Type 2. 3d Illustration
Image, 0.85MB, 7000 × 3638 jpg
Prague, Czech Republic - July 10 2024: JENTADUETO Box Of Medication With LINAGLIPTIN And METFORMIN Active Substances By BOEHRINGER INGELHEIM, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.19MB, 3024 × 4032 jpg
Linagliptin, C25H28N8O2 Molecule. It Is DPP-4 Inhibitor, Used For The Treatment Of Type II Diabetes. Structural Chemical Formula On The Dark Blue Background. Vector Illustration
Vector, 0.32MB, 5855 × 4270 eps
Prague, Czech Republic - July 10 2024: JENTADUETO Box Of Medication With LINAGLIPTIN And METFORMIN Active Substances By BOEHRINGER INGELHEIM, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.22MB, 4032 × 3024 jpg
Prague,Czech Republic-August 10 2024: JENTADUETO Box Of Tablets With LINAGLIPTIN And METFORMIN Active Substances, Used For Treatment Of Type 2 Diabetes, Blood Sugar Control.
Image, 2.18MB, 3024 × 4032 jpg
Prague,Czech Republic-June 17 2024:JENTADUETO Box With Linagliptin And Metformin Active Substance By Boehringer Ingelheim,used For Treatment Of Type 2 Diabetes,High Blood Sugar,Insulin Resistance
Image, 2.19MB, 4032 × 3024 jpg
Prague, Czech Republic - July 10 2024: JENTADUETO Box Of Medication With LINAGLIPTIN And METFORMIN Active Substances By BOEHRINGER INGELHEIM, Used For Treatment Of Type 2 Diabetes And Blood Sugar Control.
Image, 2.01MB, 4032 × 3024 jpg
Prague,Czech Republic-June 17 2024:JENTADUETO Box With Linagliptin And Metformin Active Substance By Boehringer Ingelheim,used For Treatment Of Type 2 Diabetes,High Blood Sugar,Insulin Resistance
Image, 2.18MB, 4032 × 3024 jpg
Page 1 >> Next